Literature DB >> 21860035

Aggression in schizophrenia.

Mark R Serper1.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21860035      PMCID: PMC3160226          DOI: 10.1093/schbul/sbr090

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  5 in total

Review 1.  Pathways to aggression in schizophrenia affect results of treatment.

Authors:  Jan Volavka; Leslie Citrome
Journal:  Schizophr Bull       Date:  2011-05-11       Impact factor: 9.306

Review 2.  Psychopharmacology of aggression in schizophrenia.

Authors:  Peter Buckley; Leslie Citrome; Carmen Nichita; Michael Vitacco
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

Review 3.  Neurobiology of aggression and violence in schizophrenia.

Authors:  Michael Soyka
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

Review 4.  Structured assessment of violence risk in schizophrenia and other psychiatric disorders: a systematic review of the validity, reliability, and item content of 10 available instruments.

Authors:  Jay P Singh; Mark Serper; Jonathan Reinharth; Seena Fazel
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

5.  Stigma and violence: isn't it time to connect the dots?

Authors:  E Fuller Torrey
Journal:  Schizophr Bull       Date:  2011-06-07       Impact factor: 9.306

  5 in total
  3 in total

1.  Comparable level of aggression between patients with behavioural addiction and healthy subjects.

Authors:  Yui Asaoka; Moojun Won; Tomonari Morita; Emi Ishikawa; Yukiori Goto
Journal:  Transl Psychiatry       Date:  2021-07-05       Impact factor: 6.222

2.  Neural mediator of the schizotypy-antisocial behavior relationship.

Authors:  B Y H Lam; Y Yang; A Raine; T M C Lee
Journal:  Transl Psychiatry       Date:  2015-11-03       Impact factor: 6.222

3.  The effect of the medicine administration route on health-related quality of life: Results from a time trade-off survey in patients with bipolar disorder or schizophrenia in 2 Nordic countries.

Authors:  Tine Rikke Jørgensen; Charlotte Emborg; Karianne Dahlen; Mette Bøgelund; Andreas Carlborg
Journal:  BMC Psychiatry       Date:  2016-07-16       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.